Instrument NameSatellos Bioscience IncInstrument Symbol(MSCL-T)

Instrument ExchangeTSX

Announced a presentation of data at the 29th Annual Congress of the World Muscle Society taking place ...

For the three months ended June 30, 2024, reported a net loss of $6.0 million ($0.05 loss per share), ...

Today announced that Frank Gleeson, Satellos CEO, will join leading members of the Duchenne medical ...

Announced today the formation of a Clinical Advisory Board comprised of distinguished clinical research ...

/CNW/ - Frank Gleeson Co-Founder and Chief Executive Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the "Company"), and his team joined Dani...

Announced today its financial results and operational highlights for the year ended December 31, 2023. ...

Satellos Bioscience Inc is among the group of top performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price grow at a faster rate than the rest of the market so far this year. This report is generated monthly. It...